False Negatives in Ureaplasma and Mycoplasma Testing in Men
False negatives are a significant concern when testing men for Ureaplasma and Mycoplasma infections, particularly in asymptomatic men where test sensitivity is notably limited.
Test Performance Issues
The available evidence reveals several critical limitations in detecting these organisms in men:
Sensitivity Problems in Asymptomatic Men
Testing asymptomatic men for these organisms is particularly problematic due to poor test sensitivity. While specific data on Ureaplasma and Mycoplasma testing in men is limited in the provided guidelines, the CDC's recommendations for related genital pathogens (Chlamydia) provide relevant context. For asymptomatic men, EIA methods showed sensitivities as low as 30% 1, meaning up to 70% of infections could be missed. Even in symptomatic men, sensitivities typically ranged from 70-88% 1, indicating that 12-30% of true infections would yield false-negative results.
Timing-Related False Negatives
Testing too early after exposure significantly increases false-negative rates. The CDC explicitly notes that "specimens taken for testing immediately after sexual assault may yield false-negative results because of small numbers of organisms present early in infection" 1. This principle applies broadly to genital tract infections including Ureaplasma and Mycoplasma. A follow-up test 2 weeks after initial exposure is recommended to reduce false negatives 1.
Specific Testing Challenges
Culture Method Limitations
Recent research demonstrates that liquid culture methods for Ureaplasma have a false-positive rate of 7.0% 2, but more concerning is that when culture-negative broths were verified by real-time PCR, 78 out of 318 (24.5%) were actually positive 2. This suggests substantial false-negative rates with traditional culture methods.
The "Neither Test Rules Out Infection" Problem
A critical caveat: Neither culture nor non-culture tests are sufficiently sensitive to rule out infection based solely on a negative result 1. This applies to both Chlamydia testing (which shares similar testing challenges) and by extension to Ureaplasma/Mycoplasma testing.
Clinical Implications
When False Negatives Are Most Likely
False negatives are particularly common in:
- Asymptomatic men (sensitivity as low as 30% for related organisms) 1
- Early infection (within days of exposure) 1
- Low organism burden 1
- When using liquid culture alone without PCR verification 2
Colonization vs. Infection Confusion
Ureaplasma culture or NAATs are not recommended for routine screening because of high colonization rates in asymptomatic, sexually active people 3. This creates a paradox: the organisms are common commensals, yet when pathogenic, tests may miss true infections. The prevalence of asymptomatic colonization (14% in one study) 4 makes interpretation challenging even when tests are positive.
Practical Recommendations
If clinical suspicion remains high despite negative testing:
- Repeat testing 2 weeks after initial test to account for early infection false negatives 1
- Consider PCR-based methods over culture alone - PCR verification identified 24.5% more positive cases than culture 2
- Test from appropriate sites - urethral specimens in symptomatic men, first-void urine where validated 1, 3
- Recognize that negative results do not exclude infection - treat empirically if clinical syndrome strongly suggests infection 1
Gender Differences
Men have significantly lower detection rates than women (10.13% vs 24.95% growth rates, p<0.001) 5, which may reflect either true lower prevalence or greater difficulty in specimen collection and organism detection in male anatomy.
Bottom line: False negatives are common enough in men that clinicians should not rely on negative test results to exclude Ureaplasma or Mycoplasma infection when clinical suspicion is high. Consider repeat testing, use PCR-based methods when available, and maintain awareness that these organisms' pathogenic role remains controversial given high asymptomatic colonization rates 6.